Skip to main content
. 2023 Feb 26;9:20552076231158022. doi: 10.1177/20552076231158022

Table 1.

Summary of the findings.

Author, Year, Country Study focus Study design Sample characteristic VR set-up VR type VR exposure (training or intervention)
Chiang et. al., 202121
Taiwan
Medical education training Pre–post study N = 60 (physicians, nurses, therapists) VR HMD Immersive 2 h (120 min)
Hood et al., 202117
Australia
Medical education training Pilot study N = 104 (specialists, nurses, radiographers) VR HMD Immersive 21 min
Adhikari et al., 202118
UK
Medical education training Mixed-methods feasibility study N = 19 (nursing students) VR headset Immersive 20∼30 min
Andersen et al., 202122 Denmark Medical education training Explorative pilot study as an RCT N = 19 (medical students) VR HMD, controllers Immersive 20 min
Amini et al., 202137
USA
Medical education training Quasi-experimental (pilot study) N = 27 (dental residents, faculty) VR headset Immersive 30 min
Gunn et al., 202119
Australia
Medical education training Qualitative study N = 66 (UG RT, MI students) VR headset, controllers Immersive N/A
Mallik et al., 202120
UK
Medical education training Pilot study N = 39 (junior doctors) VR headset Immersive 15 min
Giordano et al., 202038
USA
Medical education training Quasi-experimental pre-post test pilot study N = 50 (UG nursing science students) Mobile VR headset (cardboard) Immersive 20 min
Slater et al., 201924
UK
Medical education training Qualitative study N = 18 (carers, befrienders, senior management) Simulation glasses, headphones, sensor gloves Immersive N/A
Hoogenes et al., 201723 Canada Medical education training Randomized comparison study N = 39 (junior, senior medical trainees, surgical students) Robotic dVSSS, dV-T simulator platform Immersive Average 2.5 h (150 min)
Chang et al., 20226
Taiwan
Medical education training RCT N = 23 (medical students) 3D VR glasses, motion sensor, 3D VR controller (CAVE VR system) Immersive 3 sessions/week for 2 weeks and each session was for 2 h (total 12 h or 720 min)
Mrakic-Sposta et al., 201839 Italy Clinical care Pilot study N = 10 (MCI patients); mean age 73.3 years Cycle-ergometer, smart garment, finger touch projector, PlayStation controller Immersive 3 sessions/week for 6 weeks (total 18 sessions) and each session was 40∼45 min
Thapa et al., 202030
Korea
Clinical care RCT N = 68 (MCI patients); mean age 72.5 years VR headset, hand controllers Immersive 3 sessions/week for 8 weeks; total duration was 100 min (three 20-min VR training sessions, and three 10-min eye relaxation)
De Luca et al., 201731
Italy
Clinical care Pilot study N = 12 (post-stroke patients); mean age 40 years BTs-nirvana Semi-immersive 3 sessions/week for 8 weeks; each session lasted 45 min
Bergmann et al., 201829 Germany Clinical care Pilot RCT (2 parallel groups) N = 20 (subacute stroke patients); mean age 64 years Display screens, robotic-assisted devices Semi-immersive 12 sessions (for 4 weeks)
Lee et al., 202027
Korea
Clinical care RCT N = 22 (sub-acute stroke patients); mean age 58.18 years Cognitive rehabilitation training system (Moto Cog) Semi-immersive 5 sessions/week for 4 weeks; each session was 30 min/day
Al-Sharman et al., 201932 Jordan Clinical care Observational cross-sectional study N = 40; (20 MS patients and 20 controls); mean age 34.7 years Nintendo Wii Plus, balance board, LCD monitor Non-immersive VR 6 weeks; every day 10-min game session
Pot-Kolder et al., 201825 Netherlands Clinical care RCT N = 116 (patients suffering from a psychotic disorder) HMD Immersive Total 16 sessions over 8–12 weeks; session lasted 1 h, 40 min
Falconer et al., 201743 UK Clinical care Mixed-methods, feasibility and acceptability study N = 15 (patients with BPD); mean age 31.2 years Desktop, mouse, keyboard Non-immersive VR 45–60 min for 2–3 days per week; for whole treatment
Yeh et al., 201733
Taiwan
Clinical care Feasibility study N = 16 (stroke patients) 3D game engine unity™ Semi-immersive 3 sessions/week for 8 weeks; each session was 30 min
Buccellato et al., 202042 US Clinical care Feasibility trial and pilot study N = 21 (participants with ABI); mean age 41 years Computer and monitor, wireless headphones, remote server, bimanual game controllers Semi-immersive 6 weeks
Mekbib et al., 202134 China Clinical care Single blind, randomized, parallel-group study N = 23 (stroke patients); mean age 56.5 years HMD, tracking device, link box Immersive 4 sessions/week for 2 weeks; each session for 1 h
Jonsdottir et al., 202135 Italy Clinical care Pilot study N = 34 (chronic stroke patients); mean age 55 years Television screen, motion sensors Semi-immersive Clinic HEAD: 3 sessions/week for 4 weeks, each 45 min (total 12 sessions) and Home HEAD: 5 sessions/week for 12 weeks (total 60 sessions)
Beverly et al., 202226 USA Clinical care Pilot study N = 90 (HCPs suffering from stress); mean age 29.5 years HMD Immersive 3-min 360° Cine-VR session
Mosso Vázquez et al., 201840 Mexico Clinical care Pilot study (randomized) N = 44 (patients needing lipoma resection) VR 3D glasses, HMD, phone (with Google Cardboard headset) Immersive Session lasted for 30 min after surgery
Ryu et al., 201828 Korea Clinical care RCT N = 69; (undergoing general anesthesia/elective surgery); mean age 7 years HMD, saturation monitor, hand and finger motion controller, leap motion controller Immersive Session was for 5 min
Osmanlliu et al., 202041 Canada Clinical care Pilot RCT N = 62 (undergoing IV procedure); mean age 11.7 years HMD Immersive Throughout the IV procedure
Karaman et al., 202116 Turkey Clinical care RCT N = 60 (during breast biopsy); mean age 43.5 years Smartphone, 3D VR Player app, VR Box Glasses Immersive Throughout the breast biopsy

UG, undergraduate; RT, radiotherapy; MI, medical imaging; RCT, randomized controlled trial; dVSSS,da Vinci surgical skills simulator; dVT,da Vinci trainer; CAVE, Cave automatic virtual environment; MCI, mild cognitive impairment; MS, multiple sclerosis; BPD, borderline personality disorder; ABI, acquired brain injury; HCPs, healthcare professionals; HEAD, Human Empowerment Aging and Disability; IV, intravenous.